221 related articles for article (PubMed ID: 31436813)
1. Validation of an LC-MS/MS Method for the Quantification of 13 Designer Benzodiazepines in Blood.
Mei V; Concheiro M; Pardi J; Cooper G
J Anal Toxicol; 2019 Oct; 43(9):688-695. PubMed ID: 31436813
[TBL] [Abstract][Full Text] [Related]
2. Fast and Sensitive Method for the Determination of 17 Designer Benzodiazepines in Hair by Liquid Chromatography-Tandem Mass Spectrometry.
DeFreitas L; Fonseca Pego AM; Kronstrand R; Lendoiro E; de Castro-Ríos A; Concheiro M
J Anal Toxicol; 2022 Oct; 46(8):852-859. PubMed ID: 35748814
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of an LC-MS-MS Method for the Detection of 40 Benzodiazepines and Three Z-Drugs in Blood and Urine by Solid-Phase Extraction.
Sofalvi S; Lavins ES; Kaspar CK; Michel HM; Mitchell-Mata CL; Huestis MA; Apollonio LG
J Anal Toxicol; 2020 Oct; 44(7):708-717. PubMed ID: 32808043
[TBL] [Abstract][Full Text] [Related]
4. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
Pettersson Bergstrand M; Helander A; Hansson T; Beck O
Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
[TBL] [Abstract][Full Text] [Related]
5. The Development and Validation of a Novel Designer Benzodiazepines Panel by LC-MS-MS.
Mastrovito RA; Papsun DM; Logan BK
J Anal Toxicol; 2021 May; 45(5):423-428. PubMed ID: 33476376
[TBL] [Abstract][Full Text] [Related]
6. Probe Electrospray Ionization Tandem Mass Spectrometry for the Detection and Quantification of Benzodiazepines.
Griffeuille P; El Balkhi S; Dulaurent S; Saint-Marcoux F
Ther Drug Monit; 2024 Mar; ():. PubMed ID: 38498915
[TBL] [Abstract][Full Text] [Related]
7. Blood concentrations of new designer benzodiazepines in forensic cases.
Høiseth G; Tuv SS; Karinen R
Forensic Sci Int; 2016 Nov; 268():35-38. PubMed ID: 27685473
[TBL] [Abstract][Full Text] [Related]
8. Novel and Nonroutine Benzodiazepines and Suvorexant by LC-MS-MS.
Garcia L; Tiscione NB; Yeatman DT; Richards-Waugh L
J Anal Toxicol; 2021 May; 45(5):462-474. PubMed ID: 33988239
[TBL] [Abstract][Full Text] [Related]
9. Urine Drug Screening in the Era of Designer Benzodiazepines: Comparison of Three Immunoassay Platforms, LC-QTOF-MS and LC-MS-MS.
Puzyrenko A; Wang D; Schneider R; Wallace G; Schreiber S; Brandt K; Gunsolus IL
J Anal Toxicol; 2022 Aug; 46(7):712-718. PubMed ID: 34557900
[TBL] [Abstract][Full Text] [Related]
10. In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases.
Pettersson Bergstrand M; Richter LHJ; Maurer HH; Wagmann L; Meyer MR
Drug Test Anal; 2019 Jan; 11(1):45-50. PubMed ID: 29996009
[TBL] [Abstract][Full Text] [Related]
11. Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry.
Pettersson Bergstrand M; Meyer MR; Beck O; Helander A
Drug Test Anal; 2018 Mar; 10(3):496-506. PubMed ID: 28677876
[TBL] [Abstract][Full Text] [Related]
12. Recent findings and advancements in the detection of designer benzodiazepines: a brief review.
Wu D; Fu L
Arh Hig Rada Toksikol; 2022; 74(4):224-231. PubMed ID: 38146763
[TBL] [Abstract][Full Text] [Related]
13. Blood Concentrations of Designer Benzodiazepines: Relation to Impairment and Findings in Forensic Cases.
Heide G; Høiseth G; Middelkoop G; Øiestad ÅML
J Anal Toxicol; 2020 Dec; 44(8):905-914. PubMed ID: 32369173
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of two LC-MS/MS methods for the detection and quantification of amphetamines, designer amphetamines, benzoylecgonine, benzodiazepines, opiates, and opioids in urine using turbulent flow chromatography.
Schaefer N; Peters B; Schmidt P; Ewald AH
Anal Bioanal Chem; 2013 Jan; 405(1):247-58. PubMed ID: 23076398
[TBL] [Abstract][Full Text] [Related]
15. Analysis of selected designer benzodiazepines by ultra high performance liquid chromatography with high-resolution time-of-flight mass spectrometry and the estimation of their partition coefficients by micellar electrokinetic chromatography.
Tomková J; Švidrnoch M; Maier V; Ondra P
J Sep Sci; 2017 May; 40(9):2037-2044. PubMed ID: 28266783
[TBL] [Abstract][Full Text] [Related]
16. An analytical strategy for designer benzodiazepines and Z-hypnotics determination in plasma samples using ultra-high performance liquid chromatography/tandem mass spectrometry after microextraction by packed sorbent.
Ares-Fuentes AM; Lorenzo RA; Fernández P; Carro AM
J Pharm Biomed Anal; 2021 Feb; 194():113779. PubMed ID: 33279303
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of designer benzodiazepines in human serum using non-aqueous capillary electrophoresis - Tandem mass spectrometry with successive multiple ionic - Polymer layer coated capillary.
Švidrnoch M; Boráňová B; Tomková J; Ondra P; Maier V
Talanta; 2018 Jan; 176():69-76. PubMed ID: 28917807
[TBL] [Abstract][Full Text] [Related]
18. Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine.
Lehmann S; Sczyslo A; Froch-Cortis J; Rothschild MA; Thevis M; Andresen-Streichert H; Mercer-Chalmers-Bender K
Forensic Sci Int; 2019 Oct; 303():109959. PubMed ID: 31546164
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics.
Moosmann B; Bisel P; Auwärter V
Drug Test Anal; 2014; 6(7-8):757-63. PubMed ID: 24604775
[TBL] [Abstract][Full Text] [Related]
20. Designer benzodiazepines' pharmacological effects and potencies: How to find the information.
El Balkhi S; Monchaud C; Herault F; Géniaux H; Saint-Marcoux F
J Psychopharmacol; 2020 Sep; 34(9):1021-1029. PubMed ID: 31971477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
